GLUE R&D Expenses
Monte Rosa Therapeutics Inc · R&D Expenses
GLUE R&D Expenses
Latest reported$170.69Mperiod ending
GLUE TTM R&D Expenses ($24.01M → $170.69M)
TTM R&D Expenses
High-resolution chart · PNG
GLUE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 170,690,000 | |
| 153,379,000 | |
| 141,500,000 | |
| 138,387,000 | |
| 129,325,000 | |
| 124,667,000 | |
| 117,606,000 | |
| 105,875,000 | |
| 106,565,000 | |
| 109,646,000 | |
| 111,272,000 | |
| 109,005,000 | |
| 102,041,000 | |
| 93,901,000 | |
| 85,061,000 | |
| 78,323,000 | |
| 72,096,000 | |
| 65,797,000 | |
| 57,155,000 | |
| 48,888,000 | |
| 39,245,000 | |
| 29,463,000 | |
| 24,005,000 |